Serum levels of metalloproteinases and their inhibitors during infection with pathogens having integrin receptor-mediated cellular entry

References

• Elkington PT, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005;142:12–20.
   PubMed Web of Science ®Google Scholar
• Webster NL, Crowe SM. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leukoc Biol 2006;80: 1052–66.
   PubMed Web of Science ®Google Scholar
• Stefanidakis M, Koivunen E. Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 2006;108:1441–50.
   PubMed Web of Science ®Google Scholar
• Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997;3:95–104.
   PubMed Web of Science ®Google Scholar
• Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, . Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995;146: 552–79.
   PubMed Web of Science ®Google Scholar
• Kanerva M, Mustonen J, Vaheri A. Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol 1998;8:67–86.
   PubMed Web of Science ®Google Scholar
• Rasche FM, Uhel B, Krüger DH, Karges W, Czock D, Hampl W, . Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis 2004;10: 1420–5.
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 1998;95:7074–9.
   PubMed Web of Science ®Google Scholar
• Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 1999;3:3951–9.
   Google Scholar
• Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999;12: 518–53.
   PubMed Web of Science ®Google Scholar
• Heinzen RA, Scidmore MA, Rockey DD, Hackstadt T. Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun 1996;64:796.
   PubMed Web of Science ®Google Scholar
• Khavkin TN. Pathologo-anatomic and experimental study of the morphology of Q-fever. Arkh Patol 1977;39:75–84.
   PubMedGoogle Scholar
• Capo C, Lindberg FP, Meconi S, Zaffran Y, Tardei G, Brown EJ, . Subversion of monocyte functions by Coxiella burnetii: impairment of the cross-talk between alphavbeta3 integrin and CR3. J Immunol 1999;163:6078–85.
   PubMed Web of Science ®Google Scholar
• Dellacasagrande J, Ghigo E, Hammami SM, Toman R, Raoult D, Capo C, Mege JL. alpha(v)beta(3) integrin and bacterial lipopolysaccharide are involved in Coxiella burnetii-stimulated production of tumor necrosis factor by human monocytes. Infect Immun 2000;68:5673–8.
   PubMedGoogle Scholar
• Škerk V, Tambić Andrašević A, Andrašević S, Sušić E, Mlinarić Džepina A, Mađarić V, . [ISKRA guidelines on antimicrobial treatment and prophylaxis of urinary tract infections – Croatian national guidelines]. Lijeć Vjesn 2009;131:105–18.
   PubMedGoogle Scholar
• Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002;4:257–71.
   PubMed Web of Science ®Google Scholar
• Eto DS, Jones TA, Sundsbak JL, Mulvey MA. Integrin- mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 2007;3:e100.
   PubMed Web of Science ®Google Scholar
• Corcoran ML, Hewitt RE, , Kleiner DE JrStetler-Stevenson WG. MMP-2: expression, activation and inhibition. Enzyme Protein 1996;49:7–19.
   PubMedGoogle Scholar
• Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, Kotra LP, . Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J Biol Chem 2000;275:2661–8.
   PubMed Web of Science ®Google Scholar
• Chromek M, Tullus K, Hertting O, Jaremko G, Khalil A, Li YH, Brauner A. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring. Pediatr Res 2003;53:698–705.
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, . Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 2006;38:867–72.
   PubMed Web of Science ®Google Scholar
• Lorente L, Martín MM, Labarta L, Díaz C, Solé-Violán J, Blanquer J, . Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009;13:R158.
   PubMed Web of Science ®Google Scholar
• Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, . Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell 2001;12:2934–46.
   PubMed Web of Science ®Google Scholar
• Luplertlop N, Missé D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, . Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep 2006;7:1176–81.
   PubMedGoogle Scholar
• Elliott MB, Welliver RC Sr, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, . Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol 2007;79:447–56.
   PubMedGoogle Scholar
• Wang P, Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, . Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol 2008;82:8978–85.
   PubMed Web of Science ®Google Scholar
• Luplertlop N, Missé D. MMP cellular responses to dengue virus infection-induced vascular leakage. Jpn J Infect Dis 2008;61:298–301.
   PubMedGoogle Scholar
• Kubelka CF, Azeredo EL, Gandini M, Oliveira-Pinto LM, Santos LB, Damasco PV, . Metalloproteinases are produced during dengue fever and MMP9 is associated with severity. J Infect 2010;61:501–5.
   PubMed Web of Science ®Google Scholar
• Verma S, Kumar M, Gurjav U, Lum S, Nerurkar VR. Reversal of West Nile virus-induced blood–brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 2010;397:130–8.
   PubMedGoogle Scholar
• Koulentaki M, Valatas V, Xidakis K, Kouroumalis A, Petinaki E, Castanas E, Kouroumalis E. Matrix metalloproteinases and their inhibitors in acute viral hepatitis. J Viral Hepat 2002;9:189–93.
   PubMedGoogle Scholar
• Jin YJ, Park I, Hong IK, Byun HJ, Choi J, Kim YM, Lee H. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/ α(v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell Signal 2011; 23:125–34.
   PubMedGoogle Scholar
• Kazes I, Elalamy I, Sraer JD, Hatmi M, Nguyen G. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood 2000;96:3064–9.
   PubMed Web of Science ®Google Scholar
• Endo T, Nakabayashi K, Sekiuchi M, Kuroda T, Soejima A, Yamada A. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining. Clin Exp Nephrol 2006;10:253–61.
   PubMedGoogle Scholar
• Sanders JS, Huitema MG, Hanemaaijer R, van Goor H, Kallenberg CG, Stegeman CA. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Renal Physiol 2007;293:F1927–34.
   PubMedGoogle Scholar